Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing

Vaccine

Volumn 29, Issue 32, 2011, Pages 5322-5328

  Lutringer Magnin, D ^a   Kalecinski, J ^b   Barone, G ^a   Leocmach, Y ^c   Regnier, V ^b   Jacquard, A C ^c   Soubeyrand, B ^c   Vanhems, P ^a   Chauvin, F ^b   Lasset, C ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c SANOFI PASTEUR   (France)

Author keywords

Acceptability; France; General practitioners; Human papillomavirus vaccination; Practice

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

ADOLESCENCE; ADULT; ARTICLE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FEMALE; FRANCE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; NORMAL HUMAN; PAPILLOMAVIRUS INFECTION; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUALLY TRANSMITTED DISEASE; UNSPECIFIED SIDE EFFECT; VACCINATION; WART VIRUS;

ADULT; AGED; DRUG APPROVAL; FEMALE; FRANCE; GENERAL PRACTITIONERS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PUBLIC HEALTH; QUESTIONNAIRES; VACCINATION;

EID: 79960294133     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.006     Document Type: Article

References (37)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
3. Anttila A., Ronco G. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009, 45:2685-2708. Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE).
4. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, K1-K16. [Suppl. 10].
5. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350.
6. Fernández M.E., Allen J.D., Mistry R., Kahn J.A. Integrating clinical, community and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health 2010, 31:235-252.
7. Lévy-Bruhl D., Bousquet V., King L.A., O'Flanagan D., Bacci S., Lopalco P.L., et al. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey. Eur J Cancer 2009, 5:2709-2713.
8. Haut Conseil de la santé publique Avis relatif à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23ans 2010, www.fncgm.com/images/Actualites_medicales_scientifiques/vaccin_pap_hcsp_12-2010.pdf; [accessed 20.04.11].
9. Calendrier des vaccinations et recommandations vaccinales 2009 selon l'avis du haut conseil de la santé publique 2009, vol. 16-17. BEH, pp. 146-76, www.invs.sante.fr/beh/2009/16_17/beh_16_17_2009.pdf; [accessed 15.01.11].
10. Scarinci I.C., Garcia F.A., Kobetz E., Partridge E.E., Brandt H.M., Bell M.C., et al. Cervical cancer prevention: new tools and old barriers. Cancer 2010, 116:2531-2542.
11. Balinska M.A. Hepatitis B vaccination and French Society ten years after the suspension of the vaccination campaign: how should we raise infant immunization coverage rates?. J Clin Virol 2009, 46:202-205.
12. Poland G.A., Spier R. Fear, misinformation, and innumerates: how the Wakefield paper, the press, and advocacy groups damaged the public health. Vaccine 2010, 28:2361-2362.
13. Davis K., Dickman E.D., Ferris D., Dias J.K. Human Papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004, 8:188-194.
14. Sussman A.L., Helitzer D., Sanders M., Urquieta B., Salvador M., Ndiaye K. HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Ann Fam Med 2007, 5:298-304.
15. Tissot A.M., Zimet G.D., Rosenthal S.L., Bernstein D.I., Wetzel C., Kahn J.A. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health 2007, 41:119-125.
16. Ishibashi K.L., Koopmans J., Curlin F.A., Alexander K.A., Ross L.F. Paediatricians' attitudes and practices towards HPV vaccination. Acta Paediatr 2008, 97:1550-1556.
17. Hopkins T.G., Wood N.J., West R.M., Darling J.C. UK health professionals' attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health 2009, 45:652-655.
18. Daley M.F., Liddon N., Crane L.A., Beaty B.L., Barrow J., Babbel C., et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 2006, 118:2280-2289.
19. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005, 18:391-398.
20. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005, 37:502-510.
21. Kahn J.A., Rosenthal S.L., Tissot A.M., Bernstein D.I., Wetzel C., Zimet G.D. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007, 7:367-373.
22. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126:425-433.
23. Piana L., Noel G., Uters M., Laporte R., Minodier P. Standpoint and practice concerning the human Papillomavirus vaccine among French family physicians. Med Mal Infect 2009, 39:789-797.
24. Duval B., Gilca V., McNeil S., Dobson S., Money D., Gemmill I.M., et al. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007, 25:7841-7847.
25. Jaspan D.M., Dunton C.J., Cook T.L. Acceptance of human papillomavirus vaccine by gynecologists in an urban setting. J Low Genit Tract Dis 2008, 12:118-121.
26. Raley J.C., Followwill K.A., Zimet G.D., Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004, 12:127-133.
27. Esposito S., Bosis S., Pelucchi C., Begliatti E., Rognoni A., Bellasio M., et al. Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine 2007, 25:6437-6446.
28. Pélissier G., Bastides F. Vaccination anti-HPV dans le cadre de la prévention du cancer du col de l'utérus en médecine générale. Rev Prat 2008, 58:25-31.
29. Marlow L.A., Wardle J., Forster A.S., Waller J. Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Community Health 2009, 63:1010-1015.
30. Zimet G.D. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005, 37:S17-S23.
31. Fahy A., Desmond D.M. Irish mothers' intentions to have daughters receive the HPV vaccine. Ir J Med Sci 2010, 179:427-430.
32. Estimation des couvertures vaccinales en secteur libéral à travers l'échantillon généraliste des bénéficiaires en France 2004-2009 2010, Institut de veille Sanitaire. http://www.invs.sante.fr/publications/2010/couverture_vaccinale_egb/rapport_couverture_vaccinale_EGB.pdf.
33. Dorleans F., Giambi C., Dematte L., Cotter S., Stefanoff P., Mereckiene J., et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010, 15(47).
34. Peto J., Gilham C., Deacon J., Taylor C., Evans C., Binns W., et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 2004, 91:942-953.
35. Mays R.M., Zimet G.D. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis 2004, 31:428-432.
36. Schuster M.A., Bell R.M., Petersen L.P., Kanouse D.E. Communication between adolescents and physicians about sexual behavior and risk prevention. Arch Pediatr Adolesc Med 1996, 150:906-913.
37. Haug C.J. Human papillomavirus vaccination - reasons for caution. N Engl J Med 2008, 359:861-862.